Literature DB >> 15813723

Presence of the LDNF glycan on the host-protective H-gal-GP fraction from Haemonchus contortus.

P Geldhof1, G F J Newlands, K Nyame, R Cummings, W D Smith, D P Knox.   

Abstract

Immunization of sheep with the gut membrane-associated protein complex H-gal-GP of adult Haemonchus contortus induces high levels of protection against a homologous challenge infection. Protection is correlated with a systemic IgG response against the antigen. Analysis of the antibody response showed that the majority of the antigen-specific IgG was of the IgG2 isotype. A substantial proportion (74%) of this response was directed against the glycan component of H-gal-GP. The high immunogenicity of the H-gal-GP glycans may be due to the presence of the fucosylated LacdiNAc (LDNF) antigen. 2D electrophoresis, Western blotting and mass spectrometry analysis of H-gal-GP showed that this glycan epitope was specifically located on a metalloendopeptidase, MEP3. MEP3 is the most abundant protein in H-gal-GP and has been identified as one of the most likely protective components of the complex. Here, we present evidence that the LDNF glycan does not contribute to the protective capacity of H-gal-GP. Animals vaccinated with reduced and denatured H-gal-GP are not protected against subsequent infection, although the antibody response against the LDNF glycan is very similar to that of animals vaccinated with the native H-gal-GP. In addition, an alternative version of H-gal-GP, H-sialgal-GP, which is equally protective, but isolated by affinity chromatography on jacalin lectin rather than peanut lectin, contains a MEP3 component which has no detectable LDNF glycan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813723     DOI: 10.1111/j.1365-3024.2005.00744.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  8 in total

1.  Vaccination-induced IgG response to Galalpha1-3GalNAc glycan epitopes in lambs protected against Haemonchus contortus challenge infection.

Authors:  Caroline M W van Stijn; Marloes van den Broek; Lonneke Vervelde; Richard A Alvarez; Richard D Cummings; Boris Tefsen; Irma van Die
Journal:  Int J Parasitol       Date:  2009-08-18       Impact factor: 3.981

2.  Two types of galactosylated fucose motifs are present on N-glycans of Haemonchus contortus.

Authors:  Katharina Paschinger; Iain B H Wilson
Journal:  Glycobiology       Date:  2015-03-04       Impact factor: 4.313

3.  N-glycans of the porcine nematode parasite Ascaris suum are modified with phosphorylcholine and core fucose residues.

Authors:  Gerald Pöltl; Denise Kerner; Katharina Paschinger; Iain B H Wilson
Journal:  FEBS J       Date:  2006-12-20       Impact factor: 5.542

4.  A novel technique for retrospective genetic analysis of the response to vaccination or infection using cell-free DNA from archived sheep serum and plasma.

Authors:  Eve Hanks; Helen Todd; Javier Palarea-Albaladejo; Tom N McNeilly; Collette Britton; Keith T Ballingall
Journal:  Vet Res       Date:  2020-02-05       Impact factor: 3.683

5.  Sweet secrets of a therapeutic worm: mass-spectrometric N-glycomic analysis of Trichuris suis.

Authors:  Iain B H Wilson; Katharina Paschinger
Journal:  Anal Bioanal Chem       Date:  2015-12-09       Impact factor: 4.142

Review 6.  How helminths use excretory secretory fractions to modulate dendritic cells.

Authors:  Rhiannon R White; Katerina Artavanis-Tsakonas
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

7.  Inhibition of Haemonchus contortus larval development by fungal lectins.

Authors:  Christian Heim; Hubertus Hertzberg; Alex Butschi; Silvia Bleuler-Martinez; Markus Aebi; Peter Deplazes; Markus Künzler; Saša Štefanić
Journal:  Parasit Vectors       Date:  2015-08-19       Impact factor: 3.876

8.  Novel expression of Haemonchus contortus vaccine candidate aminopeptidase H11 using the free-living nematode Caenorhabditis elegans.

Authors:  Brett Roberts; Aristotelis Antonopoulos; Stuart M Haslam; Alison J Dicker; Tom N McNeilly; Stephanie L Johnston; Anne Dell; David P Knox; Collette Britton
Journal:  Vet Res       Date:  2013-12-01       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.